Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
COCP
#4659
Cocrystal Pharma, Inc. Common Stock
1.5
0
USD
-1.96%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
-1.96%
Changement Mensuel
+47.06%
Evolution sur 6 mois
+41.51%
Changement Annuel
+9.49%
Clôture Précédente
1.5
3
Open
1.5
0
Bid
Ask
Low
1.5
0
High
1.5
0
Volume
20
Marchés
Actions des Marchés US
Soins de Santé
COCP
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
10.17 M
10.17 M
10.26 M
13.78 M
13.79 M
—
Valuation ratios
Enterprise value
10.69 M
7.53 M
10.52 M
9.5 M
6.47 M
34.02 M
Price to earnings ratio
-1.17
-0.91
-1.21
-1.34
-1.26
-4.72
Price to sales ratio
-126.08
-101.74
-213.51
-274.45
204.68
-385.02
Price to cash flow ratio
-1.25
-0.97
-1.13
-1.34
-1.35
-4.79
Price to book ratio
2.16
0.31
0.43
0.43
1.75
2.92
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.24
-0.22
-0.24
-0.2
-0.25
-0.9
Return on equity %
-0.34
-0.32
-0.39
-0.27
-0.38
-1.35
Return on invested capital %
-777.44
—
—
—
-603.87
—
Gross margin %
100
100
100
100
100
400
Operating margin %
3 549.45
-78.03 K
-8 432
-11.61 K
-31.01 K
-129.08 K
EBITDA margin %
—
—
—
—
—
—
Net margin %
3 589.01
-76.7 K
-8 220
-11.38 K
-30.33 K
-126.63 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
4.77
4.57
3.69
5.78
3.68
17.72
Inventory turnover
—
—
—
—
—
—
Asset turnover
-0.01
0
0
0
0
0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.31
-0.29
-0.21
-0.12
-0.15
-0.78
EBIT per share
-0.33
-0.23
-0.2
-0.19
-0.22
-0.84
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
0.97
0.68
0.47
0.7
0.62
2.47
Net current asset value per share
1.14
0.87
0.66
0.8
0.72
3.05
Tangible book value per share
0.94
0.72
0.52
0.7
0.56
2.5
Working capital per share
0.9
0.68
0.48
0.66
0.52
2.35
Book value per share
0.94
0.72
0.52
0.7
0.56
2.5
Nouvelles
Why Cocrystal Pharma Shares Are Cooling Off Monday? - Cocrystal Pharma (NASDAQ:COCP)
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.13%
L’action Cocrystal Pharma s’envole après la désignation Fast Track de la FDA
La FDA accorde le statut de procédure accélérée au médicament contre le norovirus de Cocrystal
Cocrystal débute l’administration de doses dans une étude sur le norovirus
Cocrystal begins dosing patients in norovirus challenge study
Cocrystal Pharma advances norovirus drug candidate to Phase 1b trial
Tuesday’s Insider Activity: Major Buys at CBC, COCP; Sells at ARES, RKLB
Phillip Frost achète des actions de Cocrystal Pharma (COCP) pour 18.812€
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $18,812
Cocrystal Pharma raises $1.03 million in private placement from directors
Cocrystal Pharma receives $500,000 NIH grant for influenza drug